文献速递肿瘤 PET/CT骨显像与常规 SPECT

骨质疏松在非特异性[18F]PSMA-1007骨摄取中的潜在作用

The potential role of osteoporosis in unspecific [18F]PSMA-1007 bone uptake.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2023-09-12

回顾性分析77例初诊前列腺腺癌分期[18F]PSMA-1007 PET患者,29例(38%)出现非特异性骨摄取,最常见于骨盆(69%)和肋骨(62%)。两组临床参数无显著差异,但有非特异性骨摄取组白细胞和中性粒细胞计数显著更高,BMI和骨密度数值更低但无统计学差异。作者推测非特异性骨摄取可能与骨质疏松相关,需在更大样本中进一步研究。

要点

  • 77例初诊前列腺癌患者中29例(38%)[18F]PSMA-1007 PET出现非特异性骨摄取,骨盆69%、肋骨62%。
  • 有非特异性骨摄取组白细胞和中性粒细胞计数显著高于无摄取组。
  • 有非特异性骨摄取组BMI和骨密度数值更低,但未达统计学显著差异。

核心结论

  • 在超过1/3的患者中观察到[18F]PSMA-1007 PET非特异性骨摄取。
  • 该探索性分析发现血液计数参数与非特异性[18F]PSMA-1007骨摄取之间存在显著相关性。
  • 作者推测[18F]PSMA-1007非特异性骨摄取可能与骨质疏松相关,该假设需在更大样本中探索更特异的骨质疏松标志物进一步研究。

研究设计与样本

  • 回顾性分析77例确诊前列腺腺癌的初诊患者,均行分期[18F]PSMA-1007 PET。
  • 图像定性分析由三名经验丰富的核医学科医生独立完成。
  • 按有无非特异性骨摄取将患者分为两组,收集临床信息、PET前3个月内血常规参数、BMI及CT估算的骨密度,采用Kruskal-Wallis检验和t检验比较参数。

主要发现

  • 77例中29例(38%)出现非特异性骨摄取,最常见于骨盆(69%)和肋骨(62%)。
  • 两组临床参数无显著差异。
  • 有非特异性骨摄取组白细胞和中性粒细胞计数显著更高。
  • 有非特异性骨摄取组BMI和骨密度数值更低,但无统计学差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 该假设需在更大样本中探索更特异的骨质疏松标志物进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIM: Unspecific bone uptake is one of the main limitations of PET imaging with some PSMA-targeting radiopharmaceuticals, especially with [18F]PSMA-1007. We explored the potential association between osteoporosis and the occurrence of unspecific [18F]PSMA-1007 bone uptake investigating markers which might correlate with bone mineral density. MATERIALS AND METHODS: We retrospectively analyzed treatment-naïve patients with a confirmed diagnosis of prostate adenocarcinoma who underwent staging [18F]PSMA-1007 positron emission tomography (PET). Qualitative image analysis was performed independently by three experienced nuclear medicine physicians. Patients were divided in two groups according to the presence/absence of unspecific bone uptake. Clinical information, blood count parameters (assessed within 3 months to the PET scan), body mass index (BMI), and bone density as estimated by computed tomography were collected. The Kruskal-Wallis and t-test were used to compare parameters. RESULTS: We analyzed 77 patients: 29 of them (38%) had unspecific bone uptake at [18F]PSMA-1007 PET, most commonly in the pelvic bones (69%) and ribs (62%). We did not find any significant difference in clinical parameters in the two groups. In patients with unspecific bone uptake, white blood cell, and neutrophil counts were significantly higher; in the same group, we observed lower values of BMI and bone density, although not statistically different. CONCLUSIONS: We observed unspecific bone uptake on [18F]PSMA-1007 PET in more than 1/3 of patients. In this exploratory analysis, we found a significant correlation between blood count parameters and unspecific [18F]PSMA-1007 bone uptake. We may speculate that [18F]PSMA-1007 unspecific bone uptake could be associated with osteoporosis. This hypothesis needs to be further investigated in larger populations and exploring more specific markers of osteoporosis.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Ninatti G, Pini C, Gelardi F, et al. The potential role of osteoporosis in unspecific [18F]PSMA-1007 bone uptake. Eur J Nucl Med Mol Imaging. 2023. PMID: 37698646. doi:10.1007/s00259-023-06424-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。